logo
PRACTICE GUIDELINES, CONSENSUS CONFERENCES
COMMENTARY
SELF-DIRECTED TREATMENT OF INTERMITTENT HEARTBURN
EFFICACY AND TOLERABILITY OF FAMOTIDINE IN PREVENTING HEARTBURN AND RELATED SYMPTOMS OF UPPER GASTROINTESTINAL DISCOMFORT
PHARMACOKINETICS AND PHARMACODYNAMICS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR
EFFICACY AND SAFETY OF RAMIPRIL IN HYPERTENSIVE SINGLE-KIDNEY PATIENTS
THE FOURTH INTERNATIONAL SYMPOSIUM ON CARDIOVASCULAR DRUG DEVELOPMENT Developing Drugs for Ischemic Heart Disease
DEVELOPING ANTI-COAGULANTS FOR ISCHEMIC HEART DISEASE
REGULATORY CONSIDERATIONS IN RESTENOSIS TRIALS
THE BIOLOGY OF RESTENOSIS AND THE USE OF LOW MOLECULAR WEIGHT HEPARINS
ESTROGENS IN CORONARY ARTERY DISEASE
PANEL DISCUSSION
QUANTITATIVE EEG BRAIN MAPPING IN PSYCHOTROPIC DRUG DEVELOPMENT, DRUG TREATMENT SELECTION, AND MONITORING
THE FIFTH INTERNATIONAL SYMPOSIUM ON CARDIOVASCULAR DRUG DEVELOPMENT THE US REGULATORY PROCESS ADVANCES IN CARDIOVASCULAR PHARMACOLOGY